Increased cytochrome oxidase activity in adrenal glands of thioacetamide-cirrhotic rats

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 719-723

  Méndez López, Magdalena ^a   Méndez, Marta ^a   López, Laudino ^a   Aller, Maria Angeles ^b   González Pardo, Héctor ^a   Nava, María Paz ^b   Sánchez Patán, Fernando ^b   Arias, Jaime ^b   Arias, Jorge Luis ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Adrenal gland; Cirrhosis; Cytochrome oxidase; Portal hypertension; Rat; Thioacetamide

Indexed keywords

CYTOCHROME C OXIDASE; THIOACETAMIDE;

ADRENAL CORTEX; ADRENAL GLAND; ADRENAL MEDULLA; ADRENERGIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; RAT;

EID: 33645005805     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dashti H, Jeppson B, Hägerstrand I, Hultberg B, Srinivas U, Abdulla M, Bengmark S. Thioacetamide- and carbon tetrachloride-induced liver cirrhosis. Eur Surg Res. 1989; 21: 83-91.
2. Li X, Beenjamin IS, Alexander B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. J Hepatol 2002; 36:488-93.
3. Hori N, Okanoue T, Sawa Y, Mori T, Kashima K. Hemodynamic characterization in experimental cirrhosis induced by thioacetamide administration. Dig Dis Sci 1993; 38:2195-202.
4. O'Connor TM, O'Halloran DJ, Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. Q J M 2000; 93:323-33.
5. Wong-Riley MTT. Cytochrome oxiclase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989; 12: 94-101.
6. Gonzalez-Lima F. Brain imaging of auditory learning functions in rats: studies with fluorodeoxyglucose autoradiography and cytochrome oxidase histochemistry. In: Gonzalez-Lima F, Finkenstadt TH, Sheich H, editors. London: Kluwer. Academic Publishers; 1992; p.39-109.
7. Hevner RF, Liu S, Wong-Riley MTT. A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 1995; 65: 313-42.
8. Janssem W, Fuggle SV, Rela M, Koo DDH, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002; 73: 493-99.
9. Dieguez B, Aller MA, Nava MP, Palma MD, Arias JL, Lopez L. et al. Chronic portal hypertension in the rat by triple-portal stenosing ligation. J Invest Surg 2002; 15: 329-36.
10. Castañeda B, Dubernardi-Venon W, Bandi JC, Andreu V, Perez del Pulgar S, Moitinho E, et al. The role of portal pressure in the severity of bleeding in portal hypertensive rats. Hepatology 2000; 31:581-86.
11. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology 1986; 90: 1232-40.
12. Sukekawa K. A fresh mount method for cytochrome oxidase histochemistry. Biotechnol Histochem 1991; 1: 99-101.
13. Gonzalez-Lima F, Jones D. Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal intensified histochemistry. Brain Res 1993; 60: 34-49.
14. Gonzalez-Pardo H, Novelli A, Menendez-Patterson A, Arias JL. The development of oxidative metabolism in diencephalic structures of the rat: a quantitative study. Brain Res Bull 1998; 41: 31-8.
15. Namazi MR. The cellular immunodeficiency associated with posttraumatic stress disorder may be the result of sympathetic overactivity and be correctable by beta-2-blockers. Neuroendocrinol Lett 2003; 24: 468.
16. Benedict CR, Grahame-Smith DG. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicemia, trauma and hemorrhage. Q J M 1978; 47: 1-20.
17. Fedak PWM, Verma S, Weisel RD, Li R-K. Cardiac remodeling and failure. From molecules to man (Part 1). Cardiovasc Pathol 2005; 14:1-11.
18. Kaye D, Esler M. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res 2005; 66: 256-64.
19. Henriksen JH, Moller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998; 29: 328-41.
20. Henriksen JH, Christensen NJ, Ring-Larsen H. Noradrenaline and adrenaline in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Clin Physiol 1981; 1: 293-304.
21. Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can J Gastroenterol 2001; 15: 94-106.
22. Dubuisson L, Desmouliere A, Decourt B, et al. Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatology 2002; 35: 325-31.
23. Oben A Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004; 53: 438-45.
24. Hamasaki K, Nakashima M, Naito S, Akiyama Y, Ohtsuru A, Hamanaka Y, et al. The sympathetic nervous system promotes carbon tetrachloride-induced cirrosis in rats by suppressing apoptosis and enhancing the growth of regenerating hepatocytes. J Gastroenterol 2001; 36: 111-20.
25. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-62.
26. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress (parts 1 and 2). N Engl J Med. 1988; 319: 348-53.
27. Campeau S, Day HEW, Helmreich DL, Kollach-Walker S, Watson SJ. Principles of psychoneuroendocrinology. Psychiatr Clin North Am 1998; 25: 259-76.
28. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348: 727-34.
29. Yokohama S, Yoneda M, Nakamura K, Makino I. Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats. Am J Physiol Gastrointest Liver Physiol. 1999; 276:G622-8.
30. Nakade Y, Yoneda M, Nakamura K, Makino I, Terano A. Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1782-8.
31. Maes M, Kenis G, Kubera M, Bosmans E. In humans, corticotropin releasing hormone antagonizes some of the negative immunoregulatory effects of serotonin. Neuroendocrinol Lett 2003; 24: 420-4.
32. Pruett SB. Stress and the immune system. Pathophysiology 2003; 9:133-53.
33. Luo B, Liu L, Tang L, Zhang J, Ling Y. Fallon MB. ET-1 and TNF-a in HPS: analysis in prehepatic portal hypertension and biliary and non biliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol 2004; 286: G294-303.